Display options
Cite
Patzelt J, Verschoor A, Langer HF. Platelets and the complement cascade in atherosclerosis. Front Physiol. 2015;6:49doi: 10.3389/fphys.2015.00049.
Patzelt, J., Verschoor, A., & Langer, H. F. (2015). Platelets and the complement cascade in atherosclerosis. Frontiers in physiology, 649. https://doi.org/10.3389/fphys.2015.00049
Patzelt, Johannes, et al. "Platelets and the complement cascade in atherosclerosis." Frontiers in physiology vol. 6 (2015): 49. doi: https://doi.org/10.3389/fphys.2015.00049
Patzelt J, Verschoor A, Langer HF. Platelets and the complement cascade in atherosclerosis. Front Physiol. 2015 Mar 02;6:49. doi: 10.3389/fphys.2015.00049. eCollection 2015. PMID: 25784879; PMCID: PMC4345806.
Copy Download .nbib Format: NLM
Share it on

Front Physiol. 2015 Mar 02;6:49. doi: 10.3389/fphys.2015.00049. eCollection 2015.

Platelets and the complement cascade in atherosclerosis.

Frontiers in physiology

Johannes Patzelt, Admar Verschoor, Harald F Langer

Affiliations

  1. University Clinic for Cardiovascular Medicine, University of Tuebingen Tuebingen, Germany.
  2. Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München Munich, Germany.
  3. University Clinic for Cardiovascular Medicine, University of Tuebingen Tuebingen, Germany ; Section for Cardioimmunology, Department of Cardiovascular Medicine, University of Tuebingen Tuebingen, Germany.

PMID: 25784879 PMCID: PMC4345806 DOI: 10.3389/fphys.2015.00049

Abstract

Atherosclerosis and its late sequels are still the number one cause of death in western societies. Platelets are a driving force not only during the genesis of atherosclerosis, but especially in its late stages, as evidenced by complications such as arterial thrombosis, myocardial infarction, and ischemic stroke. Atherosclerosis is increasingly recognized as an inflammatory disease, influenced by various immune mechanisms. The complement system is part of our innate immune system, and its diverse roles in atherosclerosis have become evident over the past years. In this review we identify points of intersection between platelets and the complement system and discuss their relevance for atherosclerosis. Specifically, we will focus on roles for platelets in the onset as well as progression of the disease, a possible dual role for complement in the genesis and development of atherosclerosis, and review emerging literature revealing previously unrecognized cross-talk between platelets and the complement system and discuss its possible impact for atherosclerosis. Finally, we identify limitations of current research approaches and discuss perspectives of complement modulation in the control of the disease.

Keywords: atherosclerosis; complement system proteins; inflammation; innate immunity; platelets

References

  1. JAMA. 2004 May 19;291(19):2319-27 - PubMed
  2. Circulation. 2004 Feb 3;109(4):471-5 - PubMed
  3. Thromb Haemost. 2007 Oct;98(4):806-12 - PubMed
  4. J Clin Invest. 1997 Oct 15;100(8):2085-93 - PubMed
  5. Circ Res. 2007 Jan 5;100(1):27-40 - PubMed
  6. Medicine (Baltimore). 2005 Jan;84(1):23-34 - PubMed
  7. Eur Heart J. 2005 Nov;26(21):2294-9 - PubMed
  8. Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1463-70 - PubMed
  9. Blood. 2003 Apr 1;101(7):2661-6 - PubMed
  10. Nat Med. 2003 Jan;9(1):61-7 - PubMed
  11. J Cell Biol. 2003 Mar 3;160(5):769-80 - PubMed
  12. Arterioscler Thromb Vasc Biol. 2001 Jul;21(7):1214-9 - PubMed
  13. JAMA. 2007 Jan 3;297(1):43-51 - PubMed
  14. Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):630-6 - PubMed
  15. Circulation. 2010 Sep 7;122(10):1026-36 - PubMed
  16. J Leukoc Biol. 2009 Feb;85(2):195-204 - PubMed
  17. J Clin Invest. 2005 Dec;115(12):3378-84 - PubMed
  18. Mol Immunol. 1996 Dec;33(17-18):1389-401 - PubMed
  19. Circulation. 2002 Jul 23;106(4):399-402 - PubMed
  20. J Immunol. 1982 Jul;129(1):184-9 - PubMed
  21. Am J Cardiol. 2002 Aug 15;90(4):404-8 - PubMed
  22. Blood. 2008 Jun 1;111(11):5271-81 - PubMed
  23. Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):241-7 - PubMed
  24. Circulation. 2003 Sep 9;108(10):1184-90 - PubMed
  25. Circulation. 1997 Sep 16;96(6):1809-18 - PubMed
  26. J Immunol. 2003 Nov 15;171(10):5363-71 - PubMed
  27. PLoS One. 2011 Apr 15;6(4):e18812 - PubMed
  28. Pathophysiol Haemost Thromb. 2006;35(3-4):346-54 - PubMed
  29. Cardiovasc Res. 2008 Apr 1;78(1):8-17 - PubMed
  30. J Thromb Haemost. 2008 Aug;6(8):1413-21 - PubMed
  31. Circulation. 2007 Aug 14;116(7):764-73 - PubMed
  32. J Exp Med. 2002 Sep 2;196(5):679-91 - PubMed
  33. J Immunol. 2002 Nov 15;169(10):5489-95 - PubMed
  34. Arterioscler Thromb Vasc Biol. 1998 Mar;18(3):369-78 - PubMed
  35. Immunol Today. 1991 Sep;12(9):338-42 - PubMed
  36. Acta Pathol Microbiol Scand A. 1970;78(3):284-8 - PubMed
  37. Lab Invest. 1989 Jun;60(6):747-54 - PubMed
  38. Immunol Rev. 2001 Apr;180:56-64 - PubMed
  39. J Immunol. 2001 Sep 1;167(5):2446-51 - PubMed
  40. Blood. 2008 Jun 1;111(11):5307-15 - PubMed
  41. J Exp Med. 1998 Feb 2;187(3):329-39 - PubMed
  42. Lancet. 1998 Sep 19;352(9132):959-60 - PubMed
  43. Inflammation. 2004 Aug;28(4):177-88 - PubMed
  44. Circ Res. 2012 Apr 27;110(9):1202-10 - PubMed
  45. Atherosclerosis. 2015 Feb;238(2):289-95 - PubMed
  46. Am J Pathol. 2007 Jan;170(1):416-26 - PubMed
  47. N Engl J Med. 2001 Apr 5;344(14):1058-66 - PubMed
  48. Nat Immunol. 2011 Oct 30;12(12):1194-201 - PubMed
  49. J Thromb Haemost. 2009 Nov;7(11):1935-8 - PubMed
  50. Front Physiol. 2014 Aug 08;5:294 - PubMed
  51. FASEB J. 2011 Jul;25(7):2447-55 - PubMed
  52. Circulation. 2003 Aug 5;108(5):524-9 - PubMed
  53. Curr Vasc Pharmacol. 2012 Sep;10(5):570-7 - PubMed
  54. Immunol Res. 2004;30(1):73-80 - PubMed
  55. J Thromb Haemost. 2009 May;7(5):865-70 - PubMed
  56. Lupus. 2010 Jan;19(1):52-7 - PubMed
  57. Immunol Lett. 1985;10(2):109-14 - PubMed
  58. J Thromb Haemost. 2008 Feb;6(2):235-42 - PubMed
  59. FASEB J. 2011 Jan;25(1):35-44 - PubMed
  60. J Exp Med. 2005 Mar 21;201(6):871-9 - PubMed
  61. Nat Immunol. 2010 Sep;11(9):785-97 - PubMed
  62. J Exp Med. 2000 Apr 17;191(8):1413-22 - PubMed
  63. J Exp Med. 2003 Jan 6;197(1):41-9 - PubMed
  64. J Immunol. 1997 Dec 1;159(11):5594-8 - PubMed
  65. Mol Immunol. 2004 Jul;41(8):759-66 - PubMed
  66. N Engl J Med. 1999 Jan 14;340(2):115-26 - PubMed
  67. J Immunol. 1987 Jan 1;138(1):254-8 - PubMed
  68. Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1062-7 - PubMed
  69. Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2357-61 - PubMed
  70. Circulation. 2009 Aug 4;120(5):417-26 - PubMed
  71. Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):2017-20 - PubMed
  72. J Thromb Haemost. 2011 Mar;9(3):428-40 - PubMed
  73. Immunochemistry. 1977 Nov-Dec;14(11-12):763-6 - PubMed
  74. Nat Rev Immunol. 2007 Sep;7(9):678-89 - PubMed
  75. J Cell Mol Med. 2009 Jul;13(7):1211-20 - PubMed
  76. Circulation. 2002 Jun 25;105(25):3025-31 - PubMed
  77. J Exp Med. 1983 Aug 1;158(2):603-15 - PubMed
  78. Med Interne. 1985 Jan-Mar;23(1):29-35 - PubMed
  79. Thromb Haemost. 2013 Nov;110(5):910-9 - PubMed
  80. Circ Res. 2015 Feb 13;116(4):587-99 - PubMed
  81. Eur Heart J. 2008 Sep;29(18):2195-201 - PubMed
  82. J Investig Med. 2000 May;48(3):198-202 - PubMed
  83. Microcirculation. 2009 Jan;16(1):84-96 - PubMed
  84. Atherosclerosis. 1987 May;65(1-2):1-11 - PubMed
  85. Atherosclerosis. 2007 May;192(1):40-8 - PubMed
  86. Blood. 2003 Dec 1;102(12):4021-7 - PubMed
  87. Circulation. 2002 Mar 5;105(9):1044-8 - PubMed
  88. Thromb Haemost. 2008 Mar;99(3):480-6 - PubMed
  89. Circulation. 2002 Sep 17;106(12):1523-9 - PubMed
  90. HSR Proc Intensive Care Cardiovasc Anesth. 2011;3(1):23-4 - PubMed
  91. J Exp Med. 2002 Oct 7;196(7):887-96 - PubMed
  92. J Clin Immunol. 1999 Nov;19(6):406-13 - PubMed
  93. J Immunol. 2010 Mar 1;184(5):2686-92 - PubMed
  94. Mol Immunol. 2007 Sep;44(16):3866-74 - PubMed
  95. Atherosclerosis. 1988 Nov;74(1-2):179-86 - PubMed

Publication Types